Overview

Ivermectin in the Treatment of Head Lice

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare 2 single doses of ivermectin as tablets with 2 single applications of malathion 0.5% lotion (Days 1 and 8) in clearing head lice, in patients who have recently used standard head lice treatments without success.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide
Treatments:
Ivermectin
Malathion